Chairs
- Peter A. Fasching (Erlangen, Germany)
Welcome and introduction (ID 186)
Lecture Time
12:30 - 13:30
Speakers
- Peter A. Fasching (Erlangen, Germany)
Authors
- Peter A. Fasching (Erlangen, Germany)
Patient case 1: The importance of accurately identifying HER2 status (ID 187)
Lecture Time
13:30 - 13:30
Speakers
- Magali Lacroix-Triki (Villejuif, France)
Authors
- Magali Lacroix-Triki (Villejuif, France)
Patient case 2: Treatment options for patients with HER2-low expressing tumours (ID 188)
Lecture Time
13:30 - 13:30
Speakers
- Peter A. Fasching (Erlangen, Germany)
Authors
- Peter A. Fasching (Erlangen, Germany)
Patient case 3: Optimising adverse events management in HER2+ metastatic breast cancer (ID 189)
Lecture Time
13:30 - 13:30
Speakers
- Cristina Saura Manich (Barcelona, Spain)
Authors
- Cristina Saura Manich (Barcelona, Spain)
Panel discussion and Q&A (ID 190)
Lecture Time
13:30 - 13:45
Speakers
- To be Announced (Barcelona, Spain)
Authors
- To be Announced (Barcelona, Spain)
Closing remarks (ID 191)
Lecture Time
13:45 - 13:50
Speakers
- Peter A. Fasching (Erlangen, Germany)
Authors
- Peter A. Fasching (Erlangen, Germany)